ArticleEuropean journal of clinical pharmacology2026

Effects of renal impairment on the pharmacokinetics, safety, and tolerability of pudexacianinium (ASP5354) after IV administration: a mechanistic exploration.

Tomoki Kojima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.